Iwahata Yuriko, Iwahata Hideyuki, Hasegawa Junichi, Homma Chika, Nishimura Yoko, Kondo Haruhiro, Suzuki Nao
Department Obstetrics and Gynecology, St. Marianna University School of Medicine, Kawasaki, Japan.
Case Rep Perinat Med. 2022 Jun 11;11(1):20210032. doi: 10.1515/crpm-2021-0032. eCollection 2022 Jan.
To present a case of fetal hemothorax after two times of thoracoamniotic shunting (TAS) performed to pleural effusion with hydrops fetalis, resulting in non-reassuring fetal status due to hemothorax.
This is a case of bilateral pleural effusion with hydrops fetalis and polyhydramnios at 32 weeks gestation, in which unilateral fetal TAS was performed twice, resulting in non-reassuring fetal status due to hemothorax. After delivery, the infant was diagnosed with trisomy 21 and transient myeloproliferative disorder (TMD) with disseminated intravascular coagulation and congenital systemic lymphangiopathy.
In conclusion, since TAM case do not always show hemothrax, TAM is not inhibited but technical carefulness should be necessary.
呈现一例胎儿胸腔积液并伴有胎儿水肿,在进行两次胸腔羊膜腔分流术(TAS)后发生胎儿血胸,导致胎儿状况令人担忧的病例。
这是一例孕32周时出现双侧胸腔积液、胎儿水肿和羊水过多的病例,其中单侧胎儿TAS进行了两次,因血胸导致胎儿状况令人担忧。分娩后,婴儿被诊断为21三体综合征、伴有弥散性血管内凝血的短暂性骨髓增殖性疾病(TMD)和先天性全身淋巴管病。
总之,由于TAM病例并非总是出现血胸,TAM不应被禁止,但操作时应谨慎。